<産業資料/調査レポートの題名> 2022年7月15日

インターベンショナル神経学の世界市場:製品別(動脈瘤コイル塞栓術デバイス、脳バルーン血管形成術&ステントシステム、サポートデバイス、神経血栓摘出デバイス)、疾患病理学別(虚血性脳卒中、脳動脈瘤、動静脈奇形&瘻孔、その他の疾患病理学)


◆英文タイトル:Global Interventional Neurology Market Size study, by Product (Aneurysm Coiling & Embolization Devices, Cerebral Balloon Angioplasty and Stenting Systems, Support Devices, Neurothrombectomy Devices) By Disease Pathology (Ischemic Strokes, Cerebral Aneurysms, Arteriovenous Malformation and Fistulas, Other Disease Pathologies) and regional forecasts 2019-2026.

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1. Interventional Neurology Market, by Region, 2017-2026 (USD Billion)
1.2.2. Interventional Neurology Market, by Product, 2017-2026 (USD Billion)
1.2.3. Interventional Neurology Market, by Disease Pathology, 2017-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Interventional Neurology Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Interventional Neurology Market Dynamics
3.1. Interventional Neurology Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Interventional Neurology Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Interventional Neurology Market, by Product
5.1. Market Snapshot
5.2. Global Interventional Neurology Market by Product, Performance – Potential Analysis
5.3. Global Interventional Neurology Market Estimates & Forecasts by Product 2016-2026 (USD Billion)
5.4. Interventional Neurology Market, Sub Segment Analysis
5.4.1. Aneurysm Coiling & Embolization Devices
5.4.2. Cerebral Balloon Angioplasty and Stenting Systems
5.4.3. Support Devices
5.4.4. Neurothrombectomy Devices
Chapter 6. Global Interventional Neurology Market, by Disease Pathology
6.1. Market Snapshot
6.2. Global Interventional Neurology Market by Disease Pathology, Performance – Potential Analysis
6.3. Global Interventional Neurology Market Estimates & Forecasts by Disease Pathology 2016-2026 (USD Billion)
6.4. Interventional Neurology Market, Sub Segment Analysis
6.4.1. Ischemic Strokes
6.4.2. Cerebral Aneurysms
6.4.3. Arteriovenous Malformation and Fistulas
6.4.4. Other Disease Pathologies
Chapter 7. Global Interventional Neurology Market, Regional Analysis
7.1. Interventional Neurology Market, Regional Market Snapshot
7.2. North America Interventional Neurology Market
7.2.1. U.S. Interventional Neurology Market
7.2.1.1. Product breakdown estimates & forecasts, 2016-2026
7.2.1.2. Disease Pathology breakdown estimates & forecasts, 2016-2026
7.2.2. Canada Interventional Neurology Market
7.3. Europe Interventional Neurology Market Snapshot
7.3.1. U.K. Interventional Neurology Market
7.3.2. Rest of Europe Interventional Neurology Market
7.4. Asia-Pacific Interventional Neurology Market Snapshot
7.4.1. China Interventional Neurology Market
7.4.2. India Interventional Neurology Market
7.4.3. Japan Interventional Neurology Market
7.4.4. Rest of Asia Pacific Interventional Neurology Market
7.5. Latin America Interventional Neurology Market Snapshot
7.5.1. Brazil Interventional Neurology Market
7.5.2. Mexico Interventional Neurology Market
7.6. Rest of The World Interventional Neurology Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Stryker Corporation
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Medtronic PLC
8.2.3. Johnson & Johnson
8.2.4. Terumo Corporation
8.2.5. Penumbra, Inc.
8.2.6. Boston Scientific Corporation
8.2.7. Microport Scientific Corporation
8.2.8. Merit Medical Systems, Inc.
8.2.9. W.L. Gore & Associates, Inc.
8.2.10. Abbott Laboratories
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark